Gene-Expression Signature Predicts Postoperative Recurrence in Stage I Non-Small Cell Lung Cancer Patients

About 30% stage I non-small cell lung cancer (NSCLC) patients undergoing resection will recur. Robust prognostic markers are required to better manage therapy options. The purpose of this study is to develop and validate a novel gene-expression signature that can predict tumor recurrence of stage I...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Yan, Wang, Liang, Liu, Pengyuan, Yang, Ping, You, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3264655/
https://www.ncbi.nlm.nih.gov/pubmed/22292069
http://dx.doi.org/10.1371/journal.pone.0030880

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3264655/
https://www.ncbi.nlm.nih.gov/pubmed/22292069
http://dx.doi.org/10.1371/journal.pone.0030880

Ejemplares similares